Skip to content

Clinical trials

Terminated Observational Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Status: Terminated Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20041
20051
20061
20073
20082
20096
20104
20116
20124
20134
20142
20155
20162
20177
20184
20191
20203
20214
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated68

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Breathe BioMedical Inc3
Indiana University3
Stanford University3
Vanderbilt-Ingram Cancer Center3
AHS Cancer Control Alberta2
AstraZeneca2
Cota Inc.2
Mayo Clinic2
Memorial Sloan Kettering Cancer Center2
Myriad Genetic Laboratories, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms68
Carcinoma, Non-Small-Cell Lung22
Neoplasms9
Breast Neoplasms7
Pancreatic Neoplasms5
Prostatic Neoplasms5
Small Cell Lung Carcinoma5
Colonic Neoplasms4
Head and Neck Neoplasms4
Brain Neoplasms3

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.